Resveratrol, a component of red wine, elicits dilation of isolated porcine retinal arterioles: Role of nitric oxide and potassium channels

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 9, 2007, Pages 4232-4239

  Nagaoka, Taiji ^a,c   Hein, Travis W ^a   Yoshida, Akitoshi ^c   Kuo, Lib ^a,b  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b TEXAS A M COLLEGE OF MEDICINE   (United States)

^c ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; FULVESTRANT; GUANYLATE CYCLASE; IBERIOTOXIN; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROPRUSSIDE SODIUM; POTASSIUM CHANNEL; RESVERATROL; SULFAPHENAZOLE; TETRYLAMMONIUM; 1H (1,2,4)OXADIAZOLO(4,3 A)QUINOXALIN 1 ONE; 1H-(1,2,4)OXADIAZOLO(4,3-A)QUINOXALIN-1-ONE; ANTIOXIDANT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FLAVONOID; OXADIAZOLE DERIVATIVE; POTASSIUM CHANNEL BLOCKING AGENT; QUINOXALINE DERIVATIVE; STILBENE DERIVATIVE; UNCLASSIFIED DRUG; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY DIAMETER; ARTERY DILATATION; ARTICLE; CALCIUM CONDUCTANCE; CANNULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG RESPONSE; ENZYME INHIBITION; FEMALE; MALE; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; RED WINE; RETINA ARTERY; SWINE; VASODILATATION; ANIMAL; ARTERIOLE; DRUG EFFECT; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VIDEORECORDING; WINE;

ANIMALS; ANTIOXIDANTS; ARTERIOLES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FEMALE; FLAVONOIDS; GUANYLATE CYCLASE; MALE; MAP KINASE SIGNALING SYSTEM; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OXADIAZOLES; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; QUINOXALINES; RETINAL ARTERY; STILBENES; SWINE; VASODILATION; VASODILATOR AGENTS; VIDEO RECORDING; WINE;

EID: 35148851909     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.07-0094     Document Type: Article

References (60)

1. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 1992;339:1523-1526.
2. German JB, Walzem RL. The health benefits of wine. Annu Rev Nutr. 2000;20:561-593.
3. Andriambeloson E, Kleschyov AL, Muller B, Beretz A, Stoclet JC, Andriantsitohalna R. Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenols in rat aorta. Br J Pharmacol. 1997;120:1053-1058.
4. Flesch M, Schwarz A, Bohm M. Effects of red and white wine on endothelium-dependent vasorelaxation of rat aorta and human coronary arteries. Am J Physiol. 1998;275:H1183-H1190.
5. Leikert JF, Rathel TR, Wohlfart P, Cheynier V, Vollmar AM, Dirsch VM. Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation. 2002;106:1614-1617.
6. Chen CK, Pace-Asciak CR. Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta. Gen Pharmacol. 1996;27:363-366.
7. Wallerath T, Deckert G, Ternes T, et al. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation. 2002;106:1652-1658.
8. Jang M, Cai L, Udeani GO, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 1997;275:218-220.
9. Bradamante S, Barenghi L, Villa A, Cardiovascular protective effects of resveratrol. Cardiovasc Drug Rev. 2004;22:169-188.
10. Sinha K, Chaudhary G, Gupta YK. Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats. Life Sci. 2002;71:655-665.
11. Wang Q, Xu J, Rottinghaus GE, et al. Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res. 2002;958:439-447.
12. Howitz KT, Bitterman KJ, Cohen HY, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 2003;425:191-196.
13. Valenzano DR, Terzibasi E, Genade T, Cattaneo A, Domenici L, Cellerino A. Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Curr Biol. 2006;16:296-300.
14. Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444:337-342.
15. Kimura Y, Okuda H. Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice. J Nutr. 2001;131:1844-1849.
16. Tseng SH, Lin SM, Chen JC, et al. Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats. Clin Cancer Res. 2004;10:2190-2202.
17. Konno S, Feke GT, Yoshida A, Fujio N, Goger DG, Buzney SM. Retinal blood flow changes in type I diabetes: a long-term follow-up study. Invest Ophthalmol Vis Sci. 1996;37:1140-1148.
18. Nagaoka T, Kitaya N, Sugawara R, et al. Alteration of choroidal circulation in the foveal region in patients with type 2 diabetes. Br J Ophthalmol. 2004;88:1060-1063.
19. ATP channels in retinal arteriolar dilation in response to adenosine. Invest Ophthalmol Vis Sci. 2005;46:2113-2119.
20. Hein TW, Xu W, Kuo L. Dilation of retinal arterioles in response to lactate: role of nitric oxide, guanylyl cyclase, and ATP-sensitive potassium channels. Invest Ophthalmol Vis Sci. 2006;47:693-699.
21. Nagaoka T, Hein TW, Yoshida A, Kuo L. Simvastatin elicits dilation of isolated porcine retinal arterioles: role of nitric oxide and mevalonate-Rho kinase pathways. Invest Ophthalmol Vis Sci. 2007;48:825-832.
22. Glucksberg MR, Dunn R. Direct measurement of retinal microvascular pressures in the live, anesthetized cat. Microvasc Res. 1993;45:158-165.
23. Kulkarni P, Joshua IG, Roberts AM, Barnes G. A novel method to assess reactivities of retinal microcirculation. Microvasc Res. 1994;48:39-49.
24. Nagaoka T, Takahashi A, Sato E, et al. Effect of systemic administration of simvastatin on retinal circulation. Arch Ophthalmol. 2006;124:665-670.
25. ATP channels. Circ Res. 1999;85:634-642.
26. Haefliger IO, Flammer J, Luscher TF. Heterogeneity of endothelium-dependent regulation in ophthalmic and ciliary arteries. Invest Ophthalmol Vis Sci. 1993;34:1722-1730.
27. 2, and prostacyclin. Pharmacol Rev. 1978;30:293-331.
28. Earley S, Pastuszyn A, Walker BR. Cytochrome p-450 epoxygenase products contribute to attenuated vasoconstriction after chronic hypoxia. Am J Physiol. 2003;285:H127-H136.
29. Oeckler RA, Kaminski PM, Wolin MS. Stretch enhances contraction of bovine coronary arteries via an NAD(P)H oxidase-mediated activation of the extracellular signal-regulated kinase mitogen-activated protein kinase cascade. Circ Res. 2003;92:23-31.
30. Jackson WF. Potassium channels in the peripheral microcirculation. Microcirculation. 2005;12:113-127.
31. Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol. 1995;268:C799-C822.
32. Hein TW, Liao JC, Kuo L. oxLDL specifically impairs endothelium- dependent, NO-mediated dilation of coronary arterioles. Am J Physiol. 2000;278:H175-H183.
33. + channel from vascular and visceral smooth muscles. Am J Physiol. 1994;267:C1231-C1238.
34. Gehm BD, McAndrews JM, Chien PY, Jameson JL. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci USA. 1997;94:14138-14143.
35. Klinge CM, Blankenship KA, Risinger KE, et al. Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells. J Biol Chem. 2005;280:7460-7468.
36. Orallo F, Alvarez E, Camina M, Leiro JM, Gomez E, Fernandez P. The possible implication of trans-Resveratrol in the cardioprotective effects of long-term moderate wine consumption. Mol Pharmacol. 2002;61:294-302.
37. Novakovic A, Gojkovic-Bukarica L, Perte M, et al. The mechanism of endothelium-independent relaxation induced by the wine polyphenol resveratrol in human internal mammary artery. J Pharmacol Sci. 2006;101:85-90.
38. Rakici O, Kiziltepe U, Coskun B, Aslamaci S, Akar F. Effects of resveratrol on vascular tone and endothelial function of human saphenous vein and internal mammary artery. Int J Cardiol. 2005;105:209-215.
39. Jager U, Nguyen-Duong H. Relaxant effect of trans-resveratrol on isolated porcine coronary arteries (in German). Arzneimittelforschung. 1999;49:207-211.
40. El-Mowafy AM. Resveratrol activates membrane-bound guanylyl cyclase in coronary arterial smooth muscle: a novel signaling mechanism in support of coronary protection. Biochem Biophys Res Commun. 2002;291:1218-1224.
41. Naderali EK, Doyle PJ, Williams G. Resveratrol induces vasorelaxation of mesenteric and uterine arteries from female guinea-pigs. Clin Sci (Lond). 2000;98:537-543.
42. Cruz MN, Luksha L, Logman H, Poston L, Agewall S, Kublickiene K. Acute responses to phytoestrogens in small arteries from men with coronary heart disease. Am J Physiol. 2006;290:H1969-H1975.
43. Li HF, Tian ZF, Qiu XQ, Wu JX, Zhang P, Jia ZJ. A study of mechanisms involved in vasodilatation induced by resveratrol in isolated porcine coronary artery. Physiol Res. 2006;55:365-372.
44. Kuo L, Davis MJ, Chilian WM. Endothelial modulation of arteriolar tone. News Physiol Sci. 1992;7:5-9.
45. Bertelli AA, Giovannini L, Stradi R, Urien S, TUlement JP, Bertelli A. Evaluation of kinetic parameters of natural phytoalexin in resveratrol orally administered in wine to rats. Drugs Exp Clin Res. 1998;24:51-55.
46. 14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sci. 2003;72:2219-2233.
47. Bertelli A, Bertelli AA, Gozzini A, Giovannini L. Plasma and tissue resveratrol concentrations and pharmacological activity. Drugs Exp Clin Res. 1998;24:133-138.
48. Naderali EK, Smith SL, Doyle PJ, Williams G. The mechanism of resveratrol-induced vasorelaxation differs in the mesenteric resistance arteries of lean and obese rats. Clin Sci (Lond). 2001;100:55-60.
49. Szewczuk LM, Penning TM. Mechanism-based inactivation of COX-1 by red wine m-hydroquinones: a structure-activity relationship study. J Nat Prod. 2004;67:1777-1782.
50. Szewczuk LM, Forti L, Stivala LA, Penning TM. Resveratrol is a peroxidase-mediated inactivator of COX-1 but not COX-2: a mechanistic approach to the design of COX-1 selective agents. J Biol Chem. 2004;279:22727-22737.
51. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Disc. 2006;5:493-506.
52. Cai H, Li Z, Davis ME, Kanner W, Harrison DG, Dudley SC Jr. Akt-dependent phosphorylation of serine 1179 and mitogen-activated protein kinase klnase/extracellular signal-regulated kinase 1/2 cooperatively mediate activation of the endothelial nitric-oxide synthase by hydrogen peroxide. Mol Pharmacol. 2003;63:325-331.
53. Das S, Tosaki A, Bagchi D, Maulik N, Das DK. Potentiation of a survival signal in the ischemic heart by resveratrol through p38 mitogen-activated protein kinase/mitogen- and stress-activated protein kinase 1/cAMP response element-binding protein signaling. J Pharmacol Exp Ther. 2006;317:980-988.
54. ATP channels. Curr Eye Res. 2002;25:23-28.
55. ATP channels mediate adenosine-induced hyperemia in retina. Invest Ophthalmol Vis Sci. 1996;37:2624-2633.
56. Boussery K, Delaey C, Van de Voorde J. The vasorelaxing effect of CGRP and natriuretic peptides in isolated bovine retinal arteries. Invest Ophthalmol Vis Sci. 2005;46:1420-1427.
57. Archer SL, Huang JM, Hampl V, Nelson DP, Shultz PJ, Weir EK. Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc Natl Acad Sci USA. 1994;91:7583-7587.
58. George MJ, Shibata EF. Regulation of calcium-activated potassium channels by S-nitrosothiol compounds and cyclic guanosine monophosphate in rabbit coronary artery myocytes. J Investig Med. 1995;43:451-458.
59. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature. 1994;368:850-853.
60. Ca in smooth muscle cells isolated from the rat mesenteric artery. Br J Pharmacol. 1998;124:1131-1140.